Potential contributions of the tobacco nicotine-derived nitrosamine ketone (NNK) in the pathogenesis of steatohepatitis in a chronic plus binge rat model of alcoholic liver disease

Alcohol Alcohol. 2015 Mar;50(2):118-31. doi: 10.1093/alcalc/agu083. Epub 2015 Jan 24.

Abstract

Aims: Alcoholic liver disease (ALD) is linked to binge drinking and cigarette smoking. Heavy chronic ± binge alcohol, or low-level exposures to dietary nitrosamines cause steatohepatitis with insulin resistance and oxidative stress in animal models. This study examines hepatotoxic effects of sub-mutagenic exposures to tobacco-specific nitrosamine (NNK) in relation to ALD.

Methods: Long Evans rats were fed liquid diets containing 0 or 26% (caloric) ethanol (EtOH) for 8 weeks. In Weeks 3 through 8, rats were treated with NNK (2 mg/kg) or saline by i.p. injection, 3×/week, and in Weeks 7 and 8, EtOH-fed rats were binge-administered 2 g/kg EtOH 3×/week; controls were given saline.

Results: EtOH ± NNK caused steatohepatitis with necrosis, disruption of the hepatic cord architecture, ballooning degeneration, early fibrosis, mitochondrial cytopathy and ER disruption. Severity of lesions was highest in the EtOH+NNK group. EtOH and NNK inhibited insulin/IGF signaling through Akt and activated pro-inflammatory cytokines, while EtOH promoted lipid peroxidation, and NNK increased apoptosis. O(6)-methyl-Guanine adducts were only detected in NNK-exposed livers.

Conclusion: Both alcohol and NNK exposures contribute to ALD pathogenesis, including insulin/IGF resistance and inflammation. The differential effects of EtOH and NNK on adduct formation are critical to ALD progression among alcoholics who smoke.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Alcoholism*
  • Animals
  • Binge Drinking*
  • Carcinogens / pharmacology*
  • Central Nervous System Depressants / pharmacology
  • Central Nervous System Depressants / toxicity
  • Disease Models, Animal
  • Endoplasmic Reticulum / drug effects
  • Endoplasmic Reticulum / metabolism
  • Ethanol / pharmacology
  • Ethanol / toxicity
  • Fatty Liver, Alcoholic / etiology
  • Fatty Liver, Alcoholic / metabolism
  • Fatty Liver, Alcoholic / pathology*
  • Hepatocytes / drug effects
  • Hepatocytes / metabolism
  • Hepatocytes / pathology
  • Insulin / metabolism
  • Insulin Resistance
  • Insulin-Like Growth Factor I / metabolism
  • Liver / drug effects*
  • Liver / metabolism
  • Liver / pathology
  • Liver Diseases, Alcoholic / metabolism
  • Liver Diseases, Alcoholic / pathology
  • Mitochondria, Liver / drug effects
  • Mitochondria, Liver / metabolism
  • Necrosis
  • Nitrosamines / pharmacology*
  • Rats
  • Rats, Long-Evans
  • Receptor, IGF Type 1 / metabolism
  • Receptor, Insulin / metabolism
  • Signal Transduction / drug effects

Substances

  • Carcinogens
  • Central Nervous System Depressants
  • Insulin
  • Nitrosamines
  • Ethanol
  • Insulin-Like Growth Factor I
  • 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
  • Receptor, IGF Type 1
  • Receptor, Insulin